Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Antibodies to ganglioside GM1 in patients with Alzheimer's disease.

Chapman J, Sela BA, Wertman E, Michaelson DM.

Neurosci Lett. 1988 Mar 31;86(2):235-40.

PMID:
3368123
2.

Autoantibody reactivity in serum of patients with Alzheimer's disease and other age-related dementias.

Schott K, Wormstall H, Dietrich M, Klein R, Batra A.

Psychiatry Res. 1996 Jan 31;59(3):251-4.

PMID:
8930031
3.

Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.

Press R, Matá S, Lolli F, Zhu J, Andersson T, Link H.

J Neurol Sci. 2001 Sep 15;190(1-2):41-7.

PMID:
11574105
4.

Antibodies against GM1 in demented patients.

Hatzifilippou E, Koutsouraki E, Banaki T, Traka M, Costa VG, Baloyannis SJ.

Am J Alzheimers Dis Other Demen. 2008 Jun-Jul;23(3):274-9. doi: 10.1177/1533317508317816. Epub 2008 May 28.

PMID:
18509104
5.

Antibodies against gangliosides in patients with dementia.

Hatzifilippou E, Koutsouraki E, Costa VG, Baloyannis SJ.

Am J Alzheimers Dis Other Demen. 2014 Dec;29(8):660-6. doi: 10.1177/1533317514534953. Epub 2014 May 16.

PMID:
24838532
6.

Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Månsson JE, Svennerholm L.

Aging (Milano). 1992 Dec;4(4):301-6.

PMID:
1294245
7.

Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.

Perez CA, Ravindranath MH, Soh D, Gonzales A, Ye W, Morton DL.

Cancer J. 2002 Sep-Oct;8(5):384-94.

PMID:
12416896
8.

Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease.

Miura Y, Miyaji K, Chai YL, Chen CL, Lai MK, Yuki N.

J Alzheimers Dis. 2014;42(4):1165-9. doi: 10.3233/JAD-140474.

PMID:
25024341
9.

[Antiganglioside autoantibody profiles in Guillain-Barré syndrome].

Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.

Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):589-97. French.

10.

[Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].

Tagawa Y, Matsumoto Y, Yuki N.

No To Shinkei. 1998 Sep;50(9):849-53. Japanese.

PMID:
9789308
11.

Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia.

Shy ME, Evans VA, Lublin FD, Knobler RL, Heiman-Patterson T, Tahmoush AJ, Parry G, Schick P, DeRyk TG.

Ann Neurol. 1989 May;25(5):511-3.

PMID:
2505666
12.

Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.

Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, Yuki N.

J Neuroimmunol. 2006 Aug;177(1-2):201-8. Epub 2006 Jul 14.

PMID:
16844234
13.

Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.

Ariga T, Kubota M, Nakane M, Oguro K, Yu RK, Ando S.

PLoS One. 2013 May 23;8(5):e63326. doi: 10.1371/journal.pone.0063326. Print 2013.

14.

Two cases of acute anti-GM1 antibody elevations in response to exogenous GM1 without neurological symptoms.

Ala TA, Perfetti PA, Frey WH 2nd.

J Neuroimmunol. 1994 Aug;53(1):109-13.

PMID:
8051293
15.

Ganglioside reactive antibodies in the neuropathy associated with celiac disease.

Alaedini A, Green PH, Sander HW, Hays AP, Gamboa ET, Fasano A, Sonnenberg M, Lewis LD, Latov N.

J Neuroimmunol. 2002 Jun;127(1-2):145-8.

PMID:
12044986
16.

The spectrum of neurologic disease associated with anti-GM1 antibodies.

Sadiq SA, Thomas FP, Kilidireas K, Protopsaltis S, Hays AP, Lee KW, Romas SN, Kumar N, van den Berg L, Santoro M, et al.

Neurology. 1990 Jul;40(7):1067-72.

PMID:
2162499
17.

Anti-GM1 ganglioside antibodies in Parkinson's disease.

Zappia M, Crescibene L, Bosco D, Arabia G, Nicoletti G, Bagalà A, Bastone L, Napoli ID, Caracciolo M, Bonavita S, Di Costanzo A, Gambardella A, Quattrone A.

Acta Neurol Scand. 2002 Jul;106(1):54-7.

PMID:
12067330
18.

The probable auto-antigenic role of lipids (anti-ganglioside antibodies) in the pathogenesis of Alzheimer's disease.

Koutsouraki E, Hatzifilippou E, Michmizos D, Banaki T, Costa V, Baloyannis S.

J Alzheimers Dis. 2014;42 Suppl 3:S163-6. doi: 10.3233/JAD-132633.

PMID:
24898654
19.
20.

Human brain gangliosides in development, aging and disease.

Kracun I, Rosner H, Drnovsek V, Heffer-Lauc M, Cosović C, Lauc G.

Int J Dev Biol. 1991 Sep;35(3):289-95.

Supplemental Content

Support Center